This high-level HLA-DR-centric overview suggests that multiple, overlapping myeloid lineages are affected through altered adhesive (CD15 and CD56) and increased co-stimulatory capacity (CD86, CD275 (ICOS-L)) in RA. The gene discussed is CD86; the disease is rheumatoid arthritis.